This paper presents an embedded platform for a mobile modelbased monitoring system for patients with type 1 or type 2 diabetes. The demonstrator consists of blood glucose and continuous glucose measurement sensors available on the market. Recordings from these devices are transmitted and stored automatically by an open source mobile application. The main feature is a model-based simulation environment including a mathematical model of the glucose-insulin homeostasis. State estimation provides a real-time estimate of the patient's status such as plasma glucose or plasma insulin concentrations. These information can be used for alerts, predictions, and closed-loop approaches to support patients in their daily diabetes management.
INTRODUCTION
Model-based monitoring is a well-established method in technical applications. It is widely used in surveillance of engines in the automotive area or in chemical process control and has become a major tool in the field of predictive maintenance. The main goal is to keep a system in operation by taking into account hidden information in measurements or system models and to automate actions in case of failures.
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Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than the author(s) must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from permissions@acm.org. CHASE '18, September 26-28, 2018 People who have diagnosed with diabetes largely manage their disease themselves under everyday life conditions (blood glucose self-management, BGSM). This requires monitoring of the current blood sugar level in order to avoid hypoglycemia or hyperglycemia. Typically, a patient records 4 to 10 values a day and decides insulin delivery depending on his meals and physical activity to maintain glucose homeostasis within the physiological range. Values taken from these glucose meters are usually written down manually or stored in a manufacturer-specific program, a mobile app, or a cloud service and evaluated afterward together with the attending physician.
By using continuous glucose measurements (CGM), it is possible to gather a patient's subcutaneous glucose concentration with a comparatively high sampling time, typically 5 min. Besides some disadvantages in terms of deviations in glucose amplitude and physiologic delay compared with plasma glucose, continuous measurements provide an insight into the dynamic behavior of the glucose-insulin homeostasis for the first time, which makes it possible to observe and process new data promptly.
If an appropriate dynamical model is available, much more information can be obtained from measurements. The data provided by the user, such as food intake and insulin delivery, can be regarded as the inputs to the system. The glucose readings as the outputs, which are computable from the model. This makes it possible to adapt the model to a patient in long-term, which can be referred to as personalization of the model. On the other hand, an estimation of system states is possible with whose help e.g. alarms at too high or too low glucose levels can be triggered. The states can also be used to improve closed-loop control algorithms of an insulin pump [4] .
The increasing emergence of mobile devices such as smartphones and tablets with sufficient computing power, as well as small and wireless sensors, however, allow the use of individualized models for state estimation as a universal, portable monitoring and diagnostic system. The demonstrator presented here acts as an open platform that enables the patient to carry out direct influence and participation in the management of his disease. An increase in the individual self-control is intended to reduce times of severe disease or help prevent short-term life-threatening complications.
METHODS 2.1 Hardware and software setup
The main setup of the presented demonstrator is depicted in Fig. 1 . It consists of the open source application xdrip+ [7] available for Android mobile operating system as a user interface and communication gateway to reading data from different glucose sensors. All data is collected within a MongoDB [5] currently installed on a Raspberry Pi 3 [8] . A model of glucose-insulin homeostasis [4] is also deployed to the device by automatic code generation for embedded targets provided by Matlab/Simulink [6] . Furthermore, different services as a web front-end or smart home components could be connected to the database as well.
The first step in monitoring the patient's status is an automatic import of the current glucose readings and the user provided meal intakes and insulin deliveries into the platform. A Dexcom G5 CGM sensor [2] is used to query the continuous glucose measurements. A Contour Next One [1] is processing blood glucose recordings. Both devices are able to automatically communicate with the xdrip+ application via Bluetooth wireless protocol. Only meal intakes and insulin doses have to be provided manually by the user. All time courses can be displayed graphically, as well as with statistical analyses. The current hardware setup is depicted in Fig. 2 .
Second, all recordings were made available to other services via a MongoDB database as a common interface.
Finally, the stored data must be processed in real-time and the results must be presented to the user again.
Provided functions
Besides communication, database, and graphical front-end, the main component of the platform is the model-based monitoring system.
While no dynamic course can be recorded if only a few plasma glucose values are used and the continuous glucose data obtained are only taken from the subcutaneous tissues, a model-based state approach is able to permanently estimate internal, unmeasurable states such as plasma glucose or insulin concentrations in real-time. Furthermore, when both inputs to the system and its outputs are provided a long-term model adaptation is possible [4] . This means that the longer the platform is used and data is recorded, the model can adapt to the user. This method is known as parameter identification. Its theory for the proposed glucose-insulin model is presented in [3] . An identification procedure investigated under everyday life conditions that uses the same sensor devices as pointed here is shown in [9] .
Since the permanent calculation of complex models costs a lot of computing power and thus consumes battery power, methods for model order reduction are ideal to reduce the computational effort [10] .
Implementation
The simulation environment used here is implemented in Matlab/Simulink. It consists of some wrapper functions to collect recordings from the database via a C-API. The data is preprocessed and converted into a format suitable for simulation. Simulation sampling time is set to 1 min. while new CGM is recorded every 5 minutes. Blood glucose values, meal intakes, and insulin injections are provided by the user at random time points.
The mathematical description of the glucose-insulin homeostasis is a set of nine nonlinear first-order differential equations in state space. An Extended Kalman-Filter estimates non-measurable states. Parameter identification is currently implemented as an off-line optimization problem. The simulation environment can be deployed to a multitude of embedded hardware via automatic code generation. At present, a Raspberry Pi and an Android device are examined, which provides a direct feedback to the user by a GUI.
CONCLUSION
The demonstrator presented in this contribution is an open platform running on a mobile device. It consists of wirelessly connected glucose sensors and an Android app. A mathematical model estimates unknown states of the personalized glucose-insulin system which provides new insights into the current status of the patient in real-time. This concept could give alerts or predictions of future glucose levels, which helps to improve patient's self-management.
